Getting to know the Association of Biomolecular Resource Facilities (ABRF)
May 4, 2023 -- The Association of Biomolecular Resource Facilities (ABRF) will hold its Annual Meeting May 7 to May 10 in Boston. ABRF is a membership organization that brings together Core facilities across the U.S. and supports more than 2,400 members at over 400 institutions including organizations in government, academia, research, industry, and commercial settings. Over 50% of its members define their area of professional responsibility as either genomics or core administration. Read More
Gene variant map helps diagnose hereditary diabetes
May 4, 2023 -- University of Copenhagen researchers are using high-throughput experiments to explore connections between inherited diseases and a specific gene called GCK. The study, published April 26 in Genome Biology, may help provide better diagnoses of hereditary diabetes and other diseases. Read More
Meeting on the Mesa comes at pivotal time for cell and gene therapy industry
October 5, 2022 -- Stakeholders from around the cell and gene therapy sector will come together during the Alliance for Regenerative Medicine’s hybrid 2022 Meeting on the Mesa, October 11-13 in Carlsbad, CA, to discuss the opportunities and challenges facing the industry. Read More
FDA creates “Super Office” to manage growing cell and gene therapy workload
October 4, 2022 -- The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies to a “Super Office” within the Center of Biologics Research and Evaluation to meet its growing cell and gene therapy workload. Read More
Rogue killer T cells contribute to autoimmunity: study
November 29, 2022 -- Scientists from the Garvan Institute of Medical Research have found new insight into the role that killer T cells play in leukemia and autoimmune disease. They contend that their findings could be helpful in narrowing down pathways to target these cells for future treatments. Read More
Scientists offer way to overcome barriers to nucleic acid delivery
November 23, 2022 -- Scientists from Australia's Monash University have suggested ways of overcoming the challenges in delivering nucleic acid therapeutics, including engineering smart, responsive, and targeted nanoparticle delivery systems. Read More
Antiviral-antibody combination improves influenza outcomes in mice
August 17, 2022 -- Researchers at McMaster University found in a mouse study that combining a class of well-known antiviral drugs and neutralizing antibodies was more effective than either approach alone, which they contend could be used to treat seasonal influenza and help prevent the next flu pandemic. Read More
New antibody neutralizes all known SARS-CoV-2 variants: study
August 12, 2022 -- An antibody developed at Boston Children’s Hospital neutralizes all known SARS-CoV-2 variants, including omicron subvariants, which may inform the design of future COVID-19 vaccines. Read More
Agilent launches cell analysis workflow automation for immuno-oncology, virology, and vaccine development
February 24, 2023 -- Agilent Technologies on Friday announced that it has integrated its xCelligence RTCA HT (real-time cell analysis high-throughput) platform with the firm’s BioTek BioSpa 8 Automated Incubator, enabling a higher level of workflow automation. Read More
Survey finds physicians are comfortable prescribing Humira biosimilars if treatments are interchangeable
February 23, 2023 -- Most specialist physicians would be comfortable prescribing biosimilar versions of adalimumab (Humira), giving a boost to the companies seeking to capitalize on its loss of exclusivity. Read More
Protein tail mutation may cause rare genetic diseases
February 13, 2023 -- Researchers from Germany found that a change in a protein’s charge disrupts cellular self-organization, resulting in an extremely rare hereditary developmental disorder called brachyphalangy-polydactyly-tibial aplasia/hypoplasia syndrome (BPTAS). Read More
MicroRNAs strongly associated with type 2 diabetes in study
February 10, 2023 -- Scientists at the NIH’s National Human Genome Research Institute (NHGRI) have found a set of small RNA molecules, called microRNAs, in human pancreatic cells that are strongly associated with type 2 diabetes. Read More
Zebrafish help scientists understand organ regeneration
September 20, 2022 -- Researchers from the Stowers Institute for Medical Research are using zebrafish to investigate how their immune systems repair and regenerate organs. The findings could potentially help alleviate human conditions that might otherwise require organ transplants and lifelong immunosuppressants. Read More
Cow mucus-derived lubricant stops HIV, herpes in lab tests
September 19, 2022 -- A synthetic prophylactic gel based on cow mucus is 70% effective against HIV and 80% effective against herpes in lab tests, a new study reveals. Read More
Video from AACC: Thermo Fisher CMO on the future of diagnostics
July 28, 2022 -- Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's sister site LabPulse.com to discuss shifts in the diagnostic testing landscape. Read More
AIDS 2022 research sheds new light on HIV cells
July 28, 2022 -- New research presented at the AIDS 2022 conference shows the HIV-infected memory CD4+ T-cell reservoir is a distinctive cell population that may be uniquely susceptible to specific targeted therapies. Read More
Science In Brief
Conferences
Connect
Latest Tweets